Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. Viberzi
1. 864821-90-9
2. Viberzi
3. Truberzi
4. Jnj-27018966
5. Eluxadoline [usan]
6. Jnj 27018966
7. 45tpj4mbq1
8. Chembl2159122
9. Chebi:85980
10. 864821-90-9 (free Base)
11. Eluxadoline (usan)
12. 5-(((s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-n-((s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic Acid
13. 5-({(4-carbamoyl-2,6-dimethyl-l-phenylalanyl)[(1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic Acid
14. Benzoic Acid, 5-((((2s)-2-amino-3-(4-(aminocarbonyl)-2,6-dimethylphenyl)-1-oxopropyl)((1s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl)amino)methyl)-2-methoxy-
15. Eluxadoline [usan:inn]
16. Unii-45tpj4mbq1
17. Benzoic Acid, 5-[[[(2s)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl]amino]methyl]-2-methoxy-
18. Viberzi (tn)
19. Eluxadoline [mi]
20. Eluxadoline [inn]
21. Eluxadoline [who-dd]
22. Gtpl7691
23. Dea No. 9725
24. Eluxadoline [nflis-drug]
25. Schembl12971682
26. Schembl17950908
27. Dtxsid70235589
28. Eluxadoline [orange Book]
29. Amy39829
30. Ex-a1169
31. Mfcd28386164
32. Zinc14210876
33. Akos030632800
34. Ccg-270093
35. Cs-3855
36. Db09272
37. Jnj27018966
38. Ncgc00485958-01
39. Ac-30329
40. As-35135
41. Hy-12247
42. Ft-0701295
43. J3.535.064k
44. A14085
45. D10403
46. Q20539232
47. 5-((((2s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl)((1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl)amino(methyl)-2-methoxybenzoic Acid
48. 5-(((s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-n-((s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic Acid
49. 5-((2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)-n-(1-(5-phenyl-1h-imidazol-2-yl)ethyl)propanamido)methyl)-2-methoxybenzoic Acid
50. 5-[[[(2s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl]-[(1s)-1-(4-phenyl-3h-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic Acid
51. 5-[[[(2s)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl]-[(1s)-1-(5-phenyl-1h-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic Acid
Molecular Weight | 569.6 g/mol |
---|---|
Molecular Formula | C32H35N5O5 |
XLogP3 | 0.9 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 11 |
Exact Mass | 569.26381923 g/mol |
Monoisotopic Mass | 569.26381923 g/mol |
Topological Polar Surface Area | 165 Ų |
Heavy Atom Count | 42 |
Formal Charge | 0 |
Complexity | 917 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of irritable bowel syndrome with diarrhea (IBS-D).
FDA Label
Truberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (IBS D).
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
A07
A - Alimentary tract and metabolism
A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents
A07D - Antipropulsives
A07DA - Antipropulsives
A07DA06 - Eluxadoline
Absorption
The oral absorption of eluxadoline is poor - estimated to be 1.02%, this could be attributed to poor in vitro GI permeability, and its zwitterionic nature leading to a negatively charged molecule across the GI pH range.
Route of Elimination
82% excreted in feces, <1% excreted in urine.
The metabolism of eluxadoline is currently unclear, however evidence suggests limited glucoronidation forms an acyl glucuronide metabolite that is then excreted into urine.
The mean plasma elimination half-life ranged from 3.7 hours to 6 hours.
Eluxadoline is a mu-opioid receptor agonis, kappa opioid receptor agonist and a delta opioid receptor antagonist. Eluxadoline is used for diarrhea predominant IBS because it reduces intestinal contractility and normalizes stress-induced acceleration of upper GI transit. Antagonistic activity at the delta receptor minimizes the constipating effect usually seen by mu-opioid receptor agonists alone. Because of it's limited systemic bioavailability, there may be less side effects associated with the use of eluxadoline in comparison with other therapies used to treat diarrhea predominant IBS.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
(S)-2-(tert-butoxy carbonylamino)-3-(4-carbamoyl-2...
CAS Number : 623950-02-7
End Use API : Eluxadoline
About The Company : Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, c...
Boc-3-Iodo-L-alanine methyl ester
CAS Number : 93267-04-0
End Use API : Eluxadoline
About The Company : Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, c...
2-Chloro-4,6-dimethoxy-1,3,5-triazine (CDMT)
CAS Number : 3140-73-6
End Use API : Eluxadoline
About The Company : Louis Pharmaceuticals Private Limited is an Advanced Intermediates Manufacturing firm. The Company is established in 2009 and has an integrated focus from vario...
Methyl 5-formyl-2-methoxybenzoate
CAS Number : 78515-16-9
End Use API : Eluxadoline
About The Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and imp...
(S)-2-((tert-Butoxycarbonyl)amino)-3-(4-carbamoyl-...
CAS Number : 623950-02-7
End Use API : Eluxadoline
About The Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and imp...
(S)-1-(4-Phenyl-1H-imidazol-2-yl)ethanamine
CAS Number : 864825-23-0
End Use API : Eluxadoline
About The Company : Sandoo Pharmaceuticals and Chemcials Co.,Ltd was established in 2009, with a young and active team, located in Ningbo, China. Specializes in exporting and imp...
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2028-07-07
US Patent Number : 9789125
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206940
Patent Use Code : U-1709
Delist Requested :
Patent Use Description : TREATMENT OF IRRITABLE...
Patent Expiration Date : 2028-07-07
Patent Expiration Date : 2025-03-14
US Patent Number : 9205076
Drug Substance Claim :
Drug Product Claim :
Application Number : 206940
Patent Use Code : U-1709
Delist Requested :
Patent Use Description : TREATMENT OF IRRITABLE...
Patent Expiration Date : 2025-03-14
Patent Expiration Date : 2025-03-14
US Patent Number : 8772325
Drug Substance Claim :
Drug Product Claim :
Application Number : 206940
Patent Use Code : U-1709
Delist Requested :
Patent Use Description : TREATMENT OF IRRITABLE...
Patent Expiration Date : 2025-03-14
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Eluxadoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eluxadoline, including repackagers and relabelers. The FDA regulates Eluxadoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eluxadoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Eluxadoline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Eluxadoline supplier is an individual or a company that provides Eluxadoline active pharmaceutical ingredient (API) or Eluxadoline finished formulations upon request. The Eluxadoline suppliers may include Eluxadoline API manufacturers, exporters, distributors and traders.
click here to find a list of Eluxadoline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Eluxadoline DMF (Drug Master File) is a document detailing the whole manufacturing process of Eluxadoline active pharmaceutical ingredient (API) in detail. Different forms of Eluxadoline DMFs exist exist since differing nations have different regulations, such as Eluxadoline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Eluxadoline DMF submitted to regulatory agencies in the US is known as a USDMF. Eluxadoline USDMF includes data on Eluxadoline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Eluxadoline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Eluxadoline suppliers with USDMF on PharmaCompass.
A Eluxadoline written confirmation (Eluxadoline WC) is an official document issued by a regulatory agency to a Eluxadoline manufacturer, verifying that the manufacturing facility of a Eluxadoline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Eluxadoline APIs or Eluxadoline finished pharmaceutical products to another nation, regulatory agencies frequently require a Eluxadoline WC (written confirmation) as part of the regulatory process.
click here to find a list of Eluxadoline suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Eluxadoline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Eluxadoline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Eluxadoline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Eluxadoline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Eluxadoline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Eluxadoline suppliers with NDC on PharmaCompass.
Eluxadoline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eluxadoline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eluxadoline GMP manufacturer or Eluxadoline GMP API supplier for your needs.
A Eluxadoline CoA (Certificate of Analysis) is a formal document that attests to Eluxadoline's compliance with Eluxadoline specifications and serves as a tool for batch-level quality control.
Eluxadoline CoA mostly includes findings from lab analyses of a specific batch. For each Eluxadoline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eluxadoline may be tested according to a variety of international standards, such as European Pharmacopoeia (Eluxadoline EP), Eluxadoline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eluxadoline USP).
LOOKING FOR A SUPPLIER?